Atlas Trials

Treatment of POEMS Syndrome With Daratumumab

Clinical trial NCT04396496 · COMPLETED

Trial details

NCT number
NCT04396496
Sponsor
University of Arkansas
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
POEMS Syndrome
Start date
2020-09-22
Primary completion
2023-08-29
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.